Comparison of ipragliflozin and pioglitazone effects on nonalcoholic fatty liver disease in patients with type 2 diabetes: a randomized, 24-week, open-label, active …

D Ito, S Shimizu, K Inoue, D Saito… - Diabetes …, 2017 - Am Diabetes Assoc
OBJECTIVE To compare the efficacy of ipragliflozin versus pioglitazone in patients with type
2 diabetes complicated by nonalcoholic fatty liver disease (NAFLD). RESEARCH DESIGN …

Detailed time course of decline in serum C-peptide levels in anti–programmed cell death-1 therapy–induced fulminant type 1 diabetes

D Saito, Y Oikawa, Y Yano, Y Ikegami… - Diabetes …, 2019 - Am Diabetes Assoc
Fulminant type 1 diabetes (FT1D) is a novel subtype of type 1 diabetes (T1D) and is
characterized by a relatively low glycated hemoglobin (HbA1c) level at onset, despite the abrupt …

Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration

…, N Satoh-Asahara, H Kitazato, D Ito, D Saito… - Endocrine …, 2020 - jstage.jst.go.jp
Sodium–glucose cotransporter-2 inhibitors (SGLT2Is) are reported to prevent cardiovascular
events by a mechanism possibly including diuresis and sodium excretion. In this respect, …

[HTML][HTML] Examination of malignant findings of thyroid nodules using thyroid ultrasonography

D Saito, R Nakajima, S Yasuda - Journal of Clinical Medicine …, 2020 - ncbi.nlm.nih.gov
Background It is important to distinguish benign thyroid nodules from malignant thyroid
nodules. Hence, this study aimed to determine the characteristics of patients with thyroid cancer …

[HTML][HTML] Effects of dapagliflozin compared with sitagliptin and metformin in drug-naïve Japanese patients with type 2 diabetes: A 12-week, open-label, randomized …

D Ito, K Inoue, D Saito, K Hamaguchi, K Kaneko… - Diabetes Therapy, 2021 - Springer
Introduction To compare the efficacy and tolerability of dapagliflozin with those of sitagliptin
and metformin in patients with type 2 diabetes who have never received glucose-lowering …

Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes

D Saito, Y Oikawa, G Mizutani, K Inoue, M Hatano… - Endocrine …, 2019 - jstage.jst.go.jp
This research aimed to examine the relationship between anti-glutamic acid decarboxylase
antibody (GADA) titers and clinical parameters at onset and to clarify the association …

Solid-liquid equilibria for ethanol–water–antipyrine and ethanol–water-4-aminoantipyrine, and their cosolvencies in ethanol–water mixture

A Saito, D Yokoi, T Tsuji, PL Kiew, M Okada… - Fluid Phase …, 2023 - Elsevier
Antipyrine and 4-aminantipyrine are pyrazolone derivatives, and they are used as raw
materials for medical drugs, catalysts and chromophores. In this study, to design the extraction …

[HTML][HTML] Intrinsic insulin secretion capacity might be preserved by discontinuing anti‐programmed cell death protein 1 antibody treatment in 'anti‐programmed cell …

G Sakai, D Saito, R Nakajima, M Hatano… - Journal of diabetes …, 2018 - ncbi.nlm.nih.gov
… Gota Sakai, 1 Daigo Saito, 1 Ritsuko Nakajima, 1 Masako Hatano, 1 Yuichi Noguchi, 1
Susumu Kurihara, 1 Shigehiro Katayama, 1 Ikuo Inoue, 1 Mitsuhiko Noda, 1 and Akira …

Viscosity of slag suspensions with a polar liquid matrix

N Saito, D Hara, S Teruya, K Nakashima - isij international, 2020 - jstage.jst.go.jp
Under the operating temperatures employed in steelmaking, most slags and fluxes often
contain solids, such as undissolved CaO and its reaction products; thus, they are more viscous …

Long‐term effects of ipragliflozin and pioglitazone on metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes: 5 year observational …

…, S Yanagisawa, K Inoue, D Saito… - Journal of Diabetes …, 2024 - Wiley Online Library
Aims/Introduction We conducted a 5 year post‐trial monitoring study of our previous
randomized 24 week, open‐label, active‐controlled trial that showed beneficial effects of …